PROFERO

Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Aug 2022)

What this means for you

This application is over — abandoned 15 Aug 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
88000887
Mark type
Stylized text
Filed
14 Jun 2018
Published for opposition
14 May 2019
Abandoned
15 Aug 2022
Attorney of record
Bradley P. Hartman

Goods and services

  • Class 001 — Chemicals: Chemical test kits for genetic testing for laboratory or research use; Assays and reagents for use in genetic research; Diagnostic preparations for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents for scientific research purposes; Reagents for scientific or medical research use; Clinical diagnostic preparations for clinical or medical laboratory use
  • Class 005 — Pharmaceuticals: Testing kits comprised of medical diagnostic reagents and assays that test for the presence of certain genetic properties; Diagnostic agents, preparations and substances for medical purposes; Medical diagnostic reagents for the analysis of genetic material; Preparations for detecting changes in genes and gene expressions for medical purposes; Chemical reagents for medical analysis; Chemical preparation for use in medical analysis, particularly DNA analysis; Pharmaceutical preparations for diagnosis and for identifying and characterizing genetic abnormalities, tracking the progress of disease and measuring the effectiveness of therapies; Genetic identity tests comprises of reagents for medical purposes; Clinical diagnostic preparations for medical use
  • Class 042 — Scientific and technological services: Laboratory diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical and scientific research in the field of genetic testing and diagnosis and treatment of medical conditions; Development of tests and laboratory testing in the field of genetics and human disease; Scientific research consulting in the field of genetics, genomics, nucleic acid sequencing, and bioinformatics; Consulting services in the field of pharmaceutical research and development and laboratory testing; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; Nucleic acid collection, testing and analysis services for scientific research purposes; Genetic testing for scientific diagnostic research purposes; Genomic testing for scientific diagnostic research purposes; Medical and scientific research, development and consulting in the field of neurology; Medical and scientific research in the field of genetics and genetic engineering; Medical and scientific research and consulting in the fields of genomics and generation sequencing; Medical and scientific research in the field of disease treatment and diagnosis; Medical and scientific research relating to the design and development of treatment therapies; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data for research or analysis purposes; Conducting clinical and pre-clinical trials; Targeted pharmaceutical drug development services; Genotyping services for research or analysis purposes; Gene screening for research or analysis purposes; Gene isolation and gene expression analysis for scientific and medical research purposes; Gene mapping; Gene analysis and biomarker discovery for scientific research and medical purposes; Research and development of identification and treatment methods for hereditary factors leading to disease; Nucleic acid-sequencing for scientific research purposes
  • Class 044 — Medical, beauty and agricultural services: Medical diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical testing, analysis, and evaluation services for medical or diagnostic purposes for providing healthcare information; Providing health care information featuring information resulting from genomic research, testing, analysis, and evaluation; Diagnosis and treatment of medical conditions, namely, of cognitive, neurological, and brain-related conditions; Providing healthcare information; Providing information in the field of disease prevention, screening, diagnosis, and treatment for medical diagnostic and treatment purposes; Medical testing services for diagnostic or treatment purposes in the medical field; Proteogenomic profiling for diagnostic or treatment purposes of cognitive, neurological, and brain-related conditions; Identification of target molecules for disease treatment, namely, treatments of cognitive, neurological, and brain-related conditions

Owner

Prosecution history

  • 15 Aug 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 15 Aug 2022 — ABANDONMENT - NO USE STATEMENT FILED
  • 13 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 12 Jan 2022 — SOU EXTENSION 5 GRANTED
  • 05 Jan 2022 — SOU EXTENSION 5 FILED
  • 12 Jan 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 05 Jan 2022 — SOU TEAS EXTENSION RECEIVED
  • 06 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 02 Jul 2021 — SOU EXTENSION 4 GRANTED
  • 02 Jul 2021 — SOU EXTENSION 4 FILED
  • 02 Jul 2021 — SOU TEAS EXTENSION RECEIVED
  • 24 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 22 Dec 2020 — SOU EXTENSION 3 GRANTED
  • 22 Dec 2020 — SOU EXTENSION 3 FILED
  • 22 Dec 2020 — SOU TEAS EXTENSION RECEIVED

View this trademark record on Marksy